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Case report
Hypercalcemia due to primary hyperparathyroidism (PHPT) is uncommon in 
children. PHPT is typically caused by a single parathyroid adenoma. Ectopic 
parathyroid adenomas account for 6%–16% of all parathyroid adenomas and are 
rare in children but should be considered in cases that present with hypercalcemia. 
We report the case of a 15-year-old boy with PHPT due to an intrathymic ectopic 
parathyroid adenoma. Neck ultrasonography and Tc-99m-sestamibi (MIBI) scanning 
with single-photon emission computed tomography/computed tomography 
(SPECT/CT) revealed ectopic parathyroid adenoma in the thymus. Video-assisted 
thoracoscopic surgery was performed to remove the ectopic parathyroid adenoma. 
Pathology showed intrathymic ectopic parathyroid adenoma. After surgery, the 
patient’s serum calcium level immediately normalized. Intact parathyroid hormone 
(iPTH) and alkaline phosphatase levels returned to normal ranges within 3 months. 
Delayed diagnosis of PHPT can cause end-organ damage; a timely diagnosis is 
especially critical to preserve bone and renal function. If ectopic parathyroid 
adenomas are well localized in preoperative imaging evaluation and intraoperative 
iPTH level decreases after resection, ectopic parathyroidectomy without bilateral 
neck exploration may be performed to avoid unnecessary morbidity.
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Hypercalcemia is uncommon in children; patients typically present with characteristic 
signs/symptoms or may be diagnosed incidentally following investigations for a variety 
of nonspecific conditions.1) The causes of hypercalcemia in children can be classified as 
parathyroid hormone (PTH)-dependent or PTH-independent and may be either congenital 
or acquired.2) Primary hyperparathyroidism (PHPT) accounts for > 90% of hypercalcemia 
in adults, and most patients with PHPT present with a single adenoma (80%) or hyperplasia 
(15%–20%) of the parathyroid gland. Parathyroid carcinoma occurs rarely, accounting for 
<1% of all cases of PHPT.3) In contrast, PHPT cases are rare in children and are likely to 
account for <5% of the cases of hypercalcemia in children.2) Pediatric PHPT may occur 
due to genetic causes, such as familial hypocalciuric hypercalcemia (FHH), familial isolated 
hyperparathyroidism, and multiple endocrine neoplasia (MEN).2,4) PHPT is caused by a 
solitary parathyroid adenoma in 80% of diagnosed adults5) and 65%–70% of children.6,7) In a 
previous study, the authors reported that ectopic parathyroid adenoma accounts for 6%–16% 
of total parathyroid adenomas, and the most common ectopic location is the thymus, which 
accounts for 38% of ectopic parathyroid adenomas.8) In all pediatric PHPT patients, surgical 
resection of the parathyroid gland is required for definitive treatment.3) After curative 
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parathyroid resection, the prognosis is usually favorable without 
complications.9)
Here, we report a rare case of PHPT due to ectopic parathy-
roid adenoma in the thymus in a 15-year-old boy along with a 
comprehensive literature review about the case.
Case report
A 15-year-old male patient was born at 29 weeks of gestation 
with a birth weight of 1.12 kg. At 3 years of age, he was diagnosed 
with cerebral palsy, spastic diplegia, and developmental delay. 
He had a history of orthopedic surgery in 2009 for progression 
of a foot deformity due to spasticity of the lower limb and 
gait disturbance. The patient was able to walk independently 
with the aid of a walker. However, due to the discomfort that 
resulted from walking with a crouching gait, a distal femoral 
extension and shortening osteotomy were planned. The initial 
preoperative laboratory evaluation indicated hypercalcemia and 
elevated alkaline phosphatase (ALP), so he was referred to the 
Department of Pediatric Endocrinology.
The patient had no family history of endocrinologic disease 
or tumor. History taking revealed no previous fracture or any 
medico-surgical history except as described above. Although 
he had reported more discomfort when walking one year 
prior, there were no specific hypercalcemia symptoms, such as 
anorexia, weight loss, or mood changes. He showed no signs 
or symptoms of nephrolithiasis. Upon physical examination, 
his height was 159 cm, which was assigned to the 3rd–5th 
percentile; his yearly growth rate was in the normal range of 
about 6 cm, and his weight was 56.9 kg, which was in the 25th–
50th percentile. There had been an increase in existing right 
genu valgum compared to that from the radiograph from the 
prior year (Fig. 1). No mass was palpable on the neck.
Laboratory evaluation showed hypercalcemia (12.8 mg/
dL; reference range, 8.5–10.5 mg/dL), hypophosphatemia (2.0 
mg/dL; reference range, 3.8–5.9 mg/dL), ALP > 2,300 IU/L 
(reference range, 81–316 IU/L), elevated intact PTH (iPTH, 
1,930 pg/mL; reference range, 15–65 pg/mL), vitamin D 
deficiency (25-OH-vitamin D level of 6.09 ng/mL; reference 
range, 30–100 ng/mL), and elevated 1a-25(OH)-vitamin 
D level (115.9 pg/mL; reference range, 19.6–54.3 pg/mL), 
which suggested PHPT rather than secondary or tertiary 
hyperparathyroidism. A 24-hour urinalysis revealed values 
suggestive of hypercalciuria (a urine-Ca-to-Cr ratio of 0.45 
[29.8 mg/dL to 66.3 mg/dL]). Fractional excretion of calcium 
was 1.3%, which favors diagnosis of PHPT rather than FHH. 
To rule out genetic forms of PHPT, next-generation sequencing 
was performed using the Illumina Nextseq550 Sequence 
System (Illumina, Inc., San Diego, CA, USA), which showed no 
significant results corresponding with the clinical findings of 
MEN1, RET, HRPT2, or CASR.
Lower-extremity computed tomography (CT) revealed 
multiple, variable-sized osteolytic lesions in the bilateral iliac 
bones, femurs, and tibia. Radiographs of the hands and skull 
also showed low bone density (Fig. 2). Dual-energy x-ray 
absorptiometry was performed, and bone mineral density 
(BMD) of the lumbar spine (L1–4) was 0.626 g/cm2 with 
a z-score of  -2.3, which is suggestive of  low BMD. Renal 
ultrasonography showed mild medullary nephrocalcinosis 
without stones or hydronephrosis.
To evaluate PHPT, neck ultrasonography and Tc-99m-
sestamibi (MIBI) scanning with single-photon emission 
computed tomography/CT (SPECT/CT) were carried out. 
Neck ultrasonography revealed no abnormal lesions except a 
Fig. 1. Long-bone radiographs were recorded yearly. This 1-year follow-up 
radiograph (B) shows increased right genu valgum (white arrow) compared to 
that of the previous year (A).
Fig. 2. Skull (A) and hand radiographs (B) indicate low bone density.
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tiny colloid cyst in the thyroid gland. The MIBI scan showed a 
round-shaped nodular lesion suggestive of ectopic parathyroid 
adenoma in the prevascular region (Fig. 3).
Oral calcidiol was started before surgery. After localizing the 
ectopic parathyroid adenoma, we consulted with endocrine 
surgeons and thoracic surgeons and finally decided to perform 
video-assisted thoracoscopic surgery. Intraoperative findings 
revealed a mass on the left side of the thymus. Thymectomy 
including the mass was performed. Intraoperative iPTH 
(ioPTH) level decreased from 1,584 pg/mL to 36.5 pg/mL, 
which is within the normal range. Sectioning of the specimen 
was performed, and it showed a whitish to tan-colored, well-
demarcated mass (2.9 cm × 1.5 cm) within the thymus (Fig. 
4). Pathological findings suggested an intrathymic ectopic 
parathyroid adenoma.
After surgery, serum calcium dropped sharply from 12.8 
mg/dL to 7.7 mg/dL. The oral calcidiol given before surgery 
was discontinued in favor of another calcium carbonate-
calcidiol combination oral agent to provide more calcium 
and calcidiol after surgery. On postoperative day 1, serum 
calcium level increased from 7.7 mg/dL to 8.1 mg/dL. The 
patient showed no signs or symptoms of hypocalcemia, so 
he was discharged on postoperative day 1 with a prescription 
for an oral agent containing elemental calcium 26.4 mg/kg/
day and cholecalciferol 2,400 IU/day. He was followed up 
on postoperative day 12 at an outpatient clinic. He showed 
normalized levels of calcium (8.9 mg/dL) and phosphate (3.6 
mg/dL). His ALP level had slightly decreased from > 2,300 IU/
L to 2,193 IU/L. The iPTH level increased from 36.5 pg/mL 
(immediately postoperatively) to 117.0 pg/mL. The 25-OH-
vitamin D level increased from 6.09 ng/mL to 20.05 ng/mL. 
Three months after surgery, the ALP level had decreased from 
2,193 IU/L to 436 IU/L, and the iPTH level fell from 117.0 pg/
Fig. 3. An ectopic parathyroid adenoma is detected in the prevascular region by 99mTc-sestamibi 
scanning (A, black arrow) and single-photon emission computed tomography/computed 
tomography (B, white arrow).
Fig. 4. The gross appearance of an ectopic parathyroid adenoma. A well-
demarcated mass 2.9 cm × 1.5 cm (black arrow) in size located within the 
thymus.










Preoperative 12.8 2.0 >2300 1930.0 6.09
POD 0 7.7 2.3 >2300 36.5 -
POD 12 8.9 3.6 2193 117.0 20.5
POD 96 9.9 5.3 436 41.6 34.44
POD, postoperative day; ALP, alkaline phosphatase; iPTH, intact parathyroid hormone.
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mL to 41.6 pg/mL, which was within the normal range (Table 1).
Discussion
Hyperparathyroidism is very rare in the pediatric population, 
with an estimated prevalence of 2–5 cases per 100,000 people6); 
PHPT due to ectopic parathyroid adenoma is extremely rare, 
with only a few published case reports.10) The most common 
ectopic site for a parathyroid gland is the thymus.8) In a study 
analyzing 202 patients with ectopic parathyroid gland, the 
ectopic parathyroid sites were most common in the thymus 
(38%), followed by the retroesophageal (31%) and intrathyroidal 
regions (18%). In our case, ectopic parathyroid adenoma was 
identified in the thymus, suggesting that this region should 
be evaluated when attempting to locate ectopic parathyroid 
adenomas in children.
Unlike adult patients, almost 80% of pediatric patients with 
PHPT were symptomatic with target organ involvement.6,9) 
However, signs and symptoms of PHPT may not be obvious in 
the early stages; therefore, diagnosis requires careful observation. 
In our case, the patient did not show specific signs or symptoms 
except increased genu valgum. As genu valgum is a rare skeletal 
manifestation in children,11) PHPT is not immediately suspected 
in the presence of this manifestation. Children with PHPT 
can present with nonspecific symptoms, such as fatigue, poor 
appetite, weight loss, headache, polyuria, polydipsia, nausea, 
emesis, abdominal pain, diarrhea, depression, or joint pain.6) 
These vague clinical manifestations of PHPT lead to delayed 
diagnosis that allows end-organ damage; a timely diagnosis 
is especially critical to preserve bone and renal function.9) 
Therefore, if children have persistent, nonspecific symptoms 
that cannot be attributed to other disease processes, screening 
laboratory studies to assess the serum levels of calcium and 
iPTH should be performed.6)
Surgical resection of  the parathyroid glands in PHPT 
provides a definitive cure. In adult populations, surgery is 
recommended if the patient meets any of the following criteria: 
hypercalcemia that is consistently >1 mg/dL above normal; 
fracture; nephrocalcinosis, hypercalciuria, and other risk factors 
for renal stones; reduced BMD (T-score<-2.5 at any site); and 
age <50 years.3,12) Therefore, all patients with PHPT in the 
pediatric age group require surgical resection for definitive 
treatment.13) Accordingly, preoperative parathyroid imaging 
to localize an ectopic parathyroid is necessary in children who 
are scheduled to undergo surgery. In a meta-analysis of 43 
preoperative localization technique studies, ultrasonography 
had a pooled sensitivity of 76.1% and a positive predictive value 
of 93.2%, while MIBI-SPECT had a sensitivity of 78.9% and 
a positive predictive value of 90.7%.14) In our case, combined 
ultrasonography and MIBI scanning with SPECT/CT 
successfully detected ectopic intrathymic parathyroid adenoma.
Most adult patients with PHPT have abnormal parathyroid 
lesions in the neck, and resection of any abnormal parathyroid 
glands can be performed through a standard cervical approach. 
Even in cases with abnormal parathyroid lesions that extend 
into the mediastinum, most can be removed through a cervical 
approach. Only 2% of all PHPT require direct mediastinal 
exploration.15,16) Traditionally, a transsternal or transthoracic 
approach involving an open technique has been used in 
cases with deep mediastinal parathyroid lesions.15) Recently, 
minimally invasive parathyroidectomy for PHPT has been 
adopted at many centers to avoid unnecessary morbidity.12) 
Recent studies have shown that minimally invasive mediastinal 
ectopic parathyroidectomy is safe and feasible if the anatomical 
position of  any lesions is well  determined and ioPTH 
monitoring is available.17,18) However, there are no specific 
guidelines for management of ectopic parathyroid adenoma 
in children. Surgical treatment for PHPT in children should 
be individualized according to nature and location of the 
abnormal parathyroid glands.6,9,10) In our case, the patient had 
no family history of endocrine tumors, and the laboratory 
findings did not suggest MEN-I, MEN-IIa, or FHH. Therefore, 
surgery was performed before the genetic results were obtained. 
However, genetic testing should be carried out in PHPT patients 
who meet the following criteria: young age (<45 years of age); 
multigland disease; carcinoma or atypical adenoma; a first-
degree relative who is a known mutation carrier; an index 
case with 2 or more MEN syndrome-associated tumors.2) In 
cases where MEN affects multiple glands, subtotal or total 
parathyroidectomy is recommended.19) If ectopic parathyroid 
adenoma is well localized and ioPTH level decreases sharply 
after resection, minimally invasive parathyroidectomy without 
bilateral neck exploration could be a better option to avoid 
unnecessary morbidity in children.
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